PMC:7556165 / 2218-2385 JSONTXT

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T6","span":{"begin":113,"end":127},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A6","pred":"meddra_id","subj":"T6","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062026"}],"text":"des, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations. In this review, we will present an ove"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"64","span":{"begin":87,"end":91},"obj":"Gene"}],"attributes":[{"id":"A64","pred":"pubann:denotes","subj":"64","obj":"Gene:59272"}],"text":"des, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations. In this review, we will present an ove"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T140","span":{"begin":87,"end":91},"obj":"Protein"}],"attributes":[{"id":"A140","pred":"uniprot_id","subj":"T140","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"des, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations. In this review, we will present an ove"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T10","span":{"begin":28,"end":33},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"des, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations. In this review, we will present an ove"}

{"project":"LitCovid-PubTator","denotations":[{"id":"64","span":{"begin":87,"end":91},"obj":"Gene"}],"attributes":[{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"Gene:59272"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"des, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations. In this review, we will present an ove"}